Results 121 to 130 of about 4,564 (158)

Strategic Reintervention With Marked Oversizing and Overexpansion in TAV-in-SAV for Hemolytic Paravalvular Leak. [PDF]

open access: yesJACC Case Rep
Saigan M   +9 more
europepmc   +1 more source

Tricuspid vs Bicuspid Aortic Valve Endocarditis: Delayed Symptom-Onset-to-Diagnosis Time in Bicuspid Patients Increases Their Complication Burden. [PDF]

open access: yesJACC Adv
Huntley GD   +10 more
europepmc   +1 more source

Predicting procedural outcomes in transcatheter aortic valve implantation: a scoping review of numerical patient-specific simulations. [PDF]

open access: yesProg Biomed Eng (Bristol)
Grossi B   +7 more
europepmc   +1 more source

A Tetrameric Biotin-Avidin Scaffold Using Anti-CD19 (FMC63) Traptavidin Fusion Enables High-Avidity CAR-T Cells for Leukemia Therapy. [PDF]

open access: yesBioconjug Chem
Ko HL   +10 more
europepmc   +1 more source

TAV-in-TAV in patients with prosthesis embolization: Impact of commissural alignment and global outcomes

International Journal of Cardiology
Optimal strategies to manage embolization of transcatheter aortic valve implantation (TAVI) devices are unclear; valve-in-valve (ViV) is often used. We aimed to describe through one-single center experience its rate, causes, consequences, and management as well as the rate and relevance of commissural alignment (CA) in this context.We identified across
Mario Garcia Gomez   +2 more
exaly   +3 more sources

A Guide to Transcatheter Aortic Valve Design and Systematic Planning for a Redo-TAV (TAV-in-TAV) Procedure

JACC: Cardiovascular Interventions
Transcatheter aortic valve replacement (TAVR) has become more common than surgical aortic valve replacement since 2016, with over 200,000 procedures globally each year. As patients increasingly outlive their TAVR devices, managing these cases is a growing concern.
Gilbert Tang   +2 more
exaly   +4 more sources

Redo transcatheter aortic valve replacement in degenerated transcatheter bioprosthesis (TAV-in-TAV)

Expert Review of Cardiovascular Therapy, 2023
With the expanding indications of transcatheter aortic valve replacement (TAVR) to younger and low-risk patients, the life expectancy of patients currently undergoing TAVR will likely outlive the durability of transcatheter bioprosthesis. Consequently, the number of failed transcatheter bioprosthesis requiring surgical valve explant or redo TAVR is ...
Juan, Sánchez-Ceña   +7 more
openaire   +2 more sources

TAV-in-TAV Versus TAV-in-SAV

Journal of the American College of Cardiology, 2021
Toby Rogers   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy